271 related articles for article (PubMed ID: 17083794)
1. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
[TBL] [Abstract][Full Text] [Related]
3. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
Liang Z; Kuang J; Lin Z
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.
Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV
J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794
[TBL] [Abstract][Full Text] [Related]
5. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
8. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant.
Qiao J; Black ME; Caruso M
Hum Gene Ther; 2000 Jul; 11(11):1569-76. PubMed ID: 10945770
[TBL] [Abstract][Full Text] [Related]
9. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
10. A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.
Lin M; Huang J; Jiang X; Zhang J; Yu H; Ye J; Zhang D
Sci Rep; 2016 Sep; 6():33524. PubMed ID: 27642033
[TBL] [Abstract][Full Text] [Related]
11. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
[TBL] [Abstract][Full Text] [Related]
13. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells.
Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS
Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216
[TBL] [Abstract][Full Text] [Related]
16. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase.
Kunishige I; Samejima Y; Shiki Y; Moriyama A; Meruelo D; Saji F; Murata Y
Gynecol Oncol; 1999 Jan; 72(1):16-25. PubMed ID: 9889024
[TBL] [Abstract][Full Text] [Related]
17. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors.
Hasegawa Y; Emi N; Shimokata K; Abe A; Kawabe T; Hasegawa T; Kirioka T; Saito H
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):655-61. PubMed ID: 8391827
[TBL] [Abstract][Full Text] [Related]
19. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
Haberkorn U; Khazaie K; Morr I; Altmann A; Müller M; van Kaick G
Nucl Med Biol; 1998 May; 25(4):367-73. PubMed ID: 9639298
[TBL] [Abstract][Full Text] [Related]
20. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
